Literature DB >> 20113906

Childhood immune thrombocytopenic purpura: diagnosis and management.

Victor Blanchette1, Paula Bolton-Maggs.   

Abstract

Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a low circulating platelet count caused by destruction of antibody-sensitized platelets in the reticuloendothelial system. ITP can be classified as childhood versus adult, acute versus chronic, and primary versus secondary. Persistence of thrombocytopenia defines the chronic form of the disorder. Secondary causes of ITP include collagen vascular disorders, immune deficiencies, and some chronic infections. This review focuses on the diagnosis and management of children who have acute and chronic ITP. Emphasis is placed on areas of controversy and new therapies. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20113906     DOI: 10.1016/j.hoc.2009.11.004

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  12 in total

1.  Rituximab in steroid refractory autoimmune hemolytic anemia.

Authors:  Nitin Gupta; Sanjeev Sharma; Tulika Seth; Pravas Mishra; Manoranjan Mahapatra; Suman Kumar; Rajan Kapoor; Narendra Agarwal
Journal:  Indian J Pediatr       Date:  2011-08-10       Impact factor: 1.967

2.  Comparative efficacy and cost effectiveness of splenectomy and thrombopoietin prior to peginterferon and ribavirin therapy with compensatory cirrhosis associated with hepatitis C and thrombocytopenia.

Authors:  Bing Li; Ying Jie Ji; Qing Shao; Zhenyu Zhu; Dong Ji; Fan Li; Guofeng Chen
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

3.  A cost-effectiveness study of intravenous immunoglobulin in childhood idiopathic thrombocytopenia purpura patients with life-threatening bleeding.

Authors:  Rosarin Sruamsiri; Piyameth Dilokthornsakul; Chayanin Pratoomsoot; Nathorn Chaiyakunapruk
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

4.  Comparative of three methods (ELIZA, MAIPA and flow cytometry) to determine anti-platelet antibody in children with ITP.

Authors:  Mohsen Hamidpour; Ghader Khalili; Nader Tajic; Bi Bi Shahin Shamsian; Rafie Hamidpour
Journal:  Am J Blood Res       Date:  2014-12-15

Review 5.  Splenectomy for immune thrombocytopenia: down but not out.

Authors:  Shruti Chaturvedi; Donald M Arnold; Keith R McCrae
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

Review 6.  Clinical practice: immune thrombocytopenia in paediatrics.

Authors:  Veerle Labarque; Chris Van Geet
Journal:  Eur J Pediatr       Date:  2014-01-05       Impact factor: 3.183

7.  Newly diagnosed immune thrombocytopenia: update on diagnosis and management.

Authors:  Deepak Bansal; Aruna Rajendran; Sunit Singhi
Journal:  Indian J Pediatr       Date:  2013-10-05       Impact factor: 1.967

Review 8.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

9.  A girl with autoimmune cytopenias, nonmalignant lymphadenopathy, and recurrent infections.

Authors:  Marjolein A C Mattheij; Ellen J H Schatorjé; Eugenie F A Gemen; Lisette van de Corput; Peet T G A Nooijen; Mirjam van der Burg; Esther de Vries
Journal:  Case Reports Immunol       Date:  2012-11-21

10.  Flow cytometric immunobead assay for quantitative detection of platelet autoantibodies in immune thrombocytopenia patients.

Authors:  Juping Zhai; Mengyuan Ding; Tianjie Yang; Bin Zuo; Zhen Weng; Yunxiao Zhao; Jun He; Qingyu Wu; Changgeng Ruan; Yang He
Journal:  J Transl Med       Date:  2017-10-23       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.